Trial Profile
Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Feb 2014 Results published in the Drugs and Aging.
- 05 Nov 2010 New trial record.